Documents in Dekker v. Weida
Court documents in the archive for this case, each with the description the archive holds and a link to the original where there is one. Documents are listed by docket entry; an attachment sits under its entry, marked with the entry number and its own number (12-3 is the third attachment to entry 12). 1,052 documents.
| Entry | Date | Document | Pages | Open |
|---|---|---|---|---|
| 179-31 | Exhibit 191 - Successful Oocyte Cryopreservation Using Letrozole as an Adjunct tExhibit 191 - Successful Oocyte Cryopreservation Using Letro · Docket 4:22-cv-00325 | 6 | View here · Original(opens another site)PDF, external | |
| 179-32 | Exhibit 192 - Experience of Chest Dysphoria and Masculinizing Chest Surgery in TExhibit 192 - Experience of Chest Dysphoria and Masculinizin · Docket 4:22-cv-00325 | 9 | View here · Original(opens another site)PDF, external | |
| 179-33 | Exhibit 193 - Breast Augmentation in Male-to-Female Transgender Patients: TechniExhibit 193 - Breast Augmentation in Male-to-Female Transgen · Docket 4:22-cv-00325 | 12 | View here · Original(opens another site)PDF, external | |
| 179-34 | Exhibit 194 - Guiding the ConversationTypes of Regret after Gender-Affirming SurExhibit 194 - Guiding the ConversationTypes of Regret after · Docket 4:22-cv-00325 | 12 | View here · Original(opens another site)PDF, external | |
| 179-35 | Exhibit 195 - Individual Treatment Progress Predicts Satisfaction with TransitioExhibit 195 - Individual Treatment Progress Predicts Satisfa · Docket 4:22-cv-00325 | 14 | View here · Original(opens another site)PDF, external | |
| 179-36 | Exhibit 196 - Sexual Experiences in Transgender People, 2018 Nikkelen & BaudewijExhibit 196 - Sexual Experiences in Transgender People, 2018 · Docket 4:22-cv-00325 | 13 | View here · Original(opens another site)PDF, external | |
| 179-37 | Exhibit 197 - Quality of Life of Treatment-Seeking Transgender Adults, 2018 NobiExhibit 197 - Quality of Life of Treatment-Seeking Transgend · Docket 4:22-cv-00325 | 22 | View here · Original(opens another site)PDF, external | |
| 179-38 | Exhibit 198 - Chest Reconstruction and Chest Dysphoria in Transmasculine MinorsExhibit 198 - Chest Reconstruction and Chest Dysphoria in Tr · Docket 4:22-cv-00325 | 6 | View here · Original(opens another site)PDF, external | |
| 179-39 | Exhibit 199 - Mental Health of Transgender Children Who Are Supported in Their IExhibit 199 - Mental Health of Transgender Children Who Are · Docket 4:22-cv-00325 | 8 | View here · Original(opens another site)PDF, external | |
| 179-40 | Exhibit 200 - Association Between Gender Confirmation Treatments and Perceived GExhibit 200 - Association Between Gender Confirmation Treatm · Docket 4:22-cv-00325 | 20 | View here · Original(opens another site)PDF, external | |
| 180 | Exhibit List (Notice of Filing, Part 6 of 10) by AUGUST DEKKER, JANE DOE, JOHN DOE, SUSAN DOE, K F, JADE LADUE, BRIT ROTHSTEIN.. (Attachments: # 1 Exhibit 201 - Male-to-Female Sex Reassignment Surgery Using the Combined Technique Leads to Increased Quality of Life in a Prospective Study, 2017 Papadopulos et al., # 2 Exhibit 202 - Sex Reassignment. Thirty Years of International Follow-up Studies After Sex Reassignment Surgery: A Comprehensive Review, 1961-1991, 1998 Pfafflin & Junge, # 3 Exhibit 203 - Advancing Methods for U.S. Transgender Health Research, 2015 Reisner, # 4 Exhibit 204 - Approach to the Patient: Transgender Youth: Endocrine Considerations, 2014 Rosenthal, # 5 Exhibit 205 - Oocyte Cryopreservation in a Transgender Male Adolescent, 2019 Rothenberg et al., # 6 Exhibit 206 - Royal College of Psychiatrists, Good Practice Guidelines for the Assessment and Treatment of Adults with Gender Dysphoria (2013)., # 7 Exhibit 207 - Transgender Associations and Possible Etiology:A Literature Review, 2017 Saleem & Rizvi, # 8 Exhibit 208 - Regret Associated with the Decision for Breast Reconstruction, 2008 Sheehan et al., # 9 Exhibit 209 - Sex Reassignment: Outcomes and Predictors of Treatment for Adolescent and Adult Transsexuals, 2005 Smith, et al., # 10 Exhibit 210 - Gender-Affirming Mastectomy Trends and Surgical Outcomes in Adolescents, 2022 Tang et al., # 11 Exhibit 211 - Mental Health Outcomes in Transgender and Nonbinary Youths Receiving Gender-Affirming Care, 2022 Tordoff et al., # 12 Exhibit 212 - Endocrinology of Transgender Medicine, 2018 Guy TSjoen et al., # 13 Exhibit 213 - Alterations in Body Uneasiness, Eating Attitudes, and Psychopathology Before and After CrossSex Hormonal Treatment in Patients with FemaletoMale Gender Dysphoria, 2018 Turan et al., # 14 Exhibit 214 - Association Between Recalled Exposure to Gender Identity Conversion Efforts and Psychological Distress and Suicide Attempts Among Transgender Adults, 2020 Turban et al., # 15 Exhibit 215 - Access to Gender-Affirming Hormones during Adolescence and Mental Health Outcomes Among Transgender Adults, 2022 Turban et al., # 16 Exhibit 216 - Pubertal Suppression for Transgender Youth and Risk of Suicidal Ideation, 2020 Turban et al., # 17 Exhibit 217 - Surgical Satisfaction, Quality of Life, and Their Association After Gender-Affirming Surgery: A Follow-up Study, 2018 van de Grift et al., # 18 Exhibit 218 - Psychological Functioning in Transgender Adolescents Before and After Gender-Affirmative Care Compared With Cisgender General Population Peers, 2020 R. van der Miesen, # 19 Exhibit 219 - Effect of Pubertal Suppression and Cross-Sex Hormone Therapy on Bone Turnover Markers and Bone Mineral Apparent Density (BMAD) in Transgender Adolescents, in Bone in Balance 2020 Vlot, # 20 Exhibit 220 - Patient Satisfaction with Breasts and Psychosocial, Sexual, and Physical Well-Being after Breast Augmentation in Male-to-Female Transsexuals, 2013 Weigert et al., # 21 Exhibit 221 - Cross-Sex Hormone Therapy in Trans Persons Is Safe and Effective at Short-Time Follow-Up, 2014 Wierckx et al., # 22 Exhibit 222 - Ten Common Questions (and Their Answers) About Off-label Drug Use, 2012 Wittich et al., # 23 Exhibit 223 - Cognitive, Emotional, and Psychosocial Functioning of Girls Treated with Pharmacological Puberty Blockage for Idiopathic Central Precocious Puberty, 2016 Wojniusz et al., # 24 Exhibit 224 - Off-label Medication Prescribing Patterns in Pediatrics: An Update, 2019 Yackey et al., # 25 Exhibit 225 - Functional Ovarian Reserve in Transgender Men Receiving Testosterone Therapy, 2021 Yaish et al., # 26 Exhibit 226 - Management of Endocrine Disease: Long term outcome of central precocious puberty, # 27 Exhibit 227 - Presidential Memorandum for the Secretary of Defense and the Secretary of Homeland Security Regarding Military Service by Transgender Individuals (March 23, 2018), # 28 Exhibit 229 - Template Notice of Adverse Benefit Determination, # 29 Exhibit 230 - Template Notice of Plan Appeal Resolution, # 30 Exhibit 231 - Sample AHCA Final Order 20-FH0855, # 31 Exhibit 232 - (Placeholder) Medical records of August Dekker, # 32 Exhibit 234 - (Placeholder) Medical records of Brit Rothstein, # 33 Exhibit 234A - (Placeholder) Medical records of Brit Rothstein, # 34 Exhibit 235 - (Placeholder) Medical records of K.F., # 35 Exhibit 235A - (Placeholder) Medical records of K.F., # 36 Exhibit 236 - (Placeholder) Medical records of S.D., # 37 Exhibit 236A - (Placeholder) Medical records of S.D., # 38 Exhibit 236B - (Placeholder) Medical records of S.D., # 39 Exhibit 236C - (Placeholder) Medical records of S.D., # 40 Exhibit 237 - (Placeholder) Dekker medical records) (MILLER, WILLIAM) (Entered: 04/27/2023)Exhibit List · Docket 4:22-cv-00325 | 8 | View here · Original(opens another site)PDF, external | |
| 180-1 | Exhibit 201 - Male-to-Female Sex Reassignment Surgery Using the Combined TechniqExhibit 201 - Male-to-Female Sex Reassignment Surgery Using · Docket 4:22-cv-00325 | 9 | View here · Original(opens another site)PDF, external | |
| 180-2 | Exhibit 202 - Sex Reassignment. Thirty Years of International Follow-up StudiesExhibit 202 - Sex Reassignment. Thirty Years of Internationa · Docket 4:22-cv-00325 | 7 | View here · Original(opens another site)PDF, external | |
| 180-3 | Exhibit 203 - Advancing Methods for U.S. Transgender Health Research, 2015 ReisnExhibit 203 - Advancing Methods for U.S. Transgender Health · Docket 4:22-cv-00325 | 11 | View here · Original(opens another site)PDF, external | |
| 180-4 | Exhibit 204 - Approach to the Patient: Transgender Youth: Endocrine ConsideratioExhibit 204 - Approach to the Patient: Transgender Youth: En · Docket 4:22-cv-00325 | 11 | View here · Original(opens another site)PDF, external | |
| 180-5 | Exhibit 205 - Oocyte Cryopreservation in a Transgender Male Adolescent, 2019 RotExhibit 205 - Oocyte Cryopreservation in a Transgender Male · Docket 4:22-cv-00325 | 2 | View here · Original(opens another site)PDF, external | |
| 180-6 | Exhibit 206 - Royal College of Psychiatrists, Good Practice Guidelines for the AExhibit 206 - Royal College of Psychiatrists, Good Practice · Docket 4:22-cv-00325 | 62 | View here · Original(opens another site)PDF, external | |
| 180-7 | Exhibit 207 - Transgender Associations and Possible Etiology:A Literature ReviewExhibit 207 - Transgender Associations and Possible Etiology · Docket 4:22-cv-00325 | 5 | View here · Original(opens another site)PDF, external | |
| 180-8 | Exhibit 208 - Regret Associated with the Decision for Breast Reconstruction, 200Exhibit 208 - Regret Associated with the Decision for Breast · Docket 4:22-cv-00325 | 15 | View here · Original(opens another site)PDF, external | |
| 180-9 | Exhibit 209 - Sex Reassignment: Outcomes and Predictors of Treatment for AdolescExhibit 209 - Sex Reassignment: Outcomes and Predictors of T · Docket 4:22-cv-00325 | 11 | View here · Original(opens another site)PDF, external | |
| 180-10 | Exhibit 210 - Gender-Affirming Mastectomy Trends and Surgical Outcomes in AdolesExhibit 210 - Gender-Affirming Mastectomy Trends and Surgica · Docket 4:22-cv-00325 | 7 | View here · Original(opens another site)PDF, external | |
| 180-11 | Exhibit 211 - Mental Health Outcomes in Transgender and Nonbinary Youths ReceiviExhibit 211 - Mental Health Outcomes in Transgender and Nonb · Docket 4:22-cv-00325 | 13 | View here · Original(opens another site)PDF, external | |
| 180-12 | Exhibit 212 - Endocrinology of Transgender Medicine, 2018 Guy TSjoen et al.Exhibit 212 - Endocrinology of Transgender Medicine, 2018 Gu · Docket 4:22-cv-00325 | 21 | View here · Original(opens another site)PDF, external | |
| 180-13 | Exhibit 213 - Alterations in Body Uneasiness, Eating Attitudes, and PsychopatholExhibit 213 - Alterations in Body Uneasiness, Eating Attitud · Docket 4:22-cv-00325 | 14 | View here · Original(opens another site)PDF, external | |
| 180-14 | Exhibit 214 - Association Between Recalled Exposure to Gender Identity ConversioExhibit 214 - Association Between Recalled Exposure to Gende · Docket 4:22-cv-00325 | 9 | View here · Original(opens another site)PDF, external | |
| 180-15 | Exhibit 215 - Access to Gender-Affirming Hormones during Adolescence and MentalExhibit 215 - Access to Gender-Affirming Hormones during Ado · Docket 4:22-cv-00325 | 15 | View here · Original(opens another site)PDF, external | |
| 180-16 | Exhibit 216 - Pubertal Suppression for Transgender Youth and Risk of Suicidal IdExhibit 216 - Pubertal Suppression for Transgender Youth and · Docket 4:22-cv-00325 | 8 | View here · Original(opens another site)PDF, external | |
| 180-17 | Exhibit 217 - Surgical Satisfaction, Quality of Life, and Their Association AfteExhibit 217 - Surgical Satisfaction, Quality of Life, and Th · Docket 4:22-cv-00325 | 12 | View here · Original(opens another site)PDF, external | |
| 180-18 | Exhibit 218 - Psychological Functioning in Transgender Adolescents Before and AfExhibit 218 - Psychological Functioning in Transgender Adole · Docket 4:22-cv-00325 | 7 | View here · Original(opens another site)PDF, external | |
| 180-19 | Exhibit 219 - Effect of Pubertal Suppression and Cross-Sex Hormone Therapy on BoExhibit 219 - Effect of Pubertal Suppression and Cross-Sex H · Docket 4:22-cv-00325 | 199 | View here · Original(opens another site)PDF, external | |
| 180-20 | Exhibit 220 - Patient Satisfaction with Breasts and Psychosocial, Sexual, and PhExhibit 220 - Patient Satisfaction with Breasts and Psychoso · Docket 4:22-cv-00325 | 9 | View here · Original(opens another site)PDF, external | |
| 180-21 | Exhibit 221 - Cross-Sex Hormone Therapy in Trans Persons Is Safe and Effective aExhibit 221 - Cross-Sex Hormone Therapy in Trans Persons Is · Docket 4:22-cv-00325 | 13 | View here · Original(opens another site)PDF, external | |
| 180-22 | Exhibit 222 - Ten Common Questions (and Their Answers) About Off-label Drug Use,Exhibit 222 - Ten Common Questions (and Their Answers) About · Docket 4:22-cv-00325 | 9 | View here · Original(opens another site)PDF, external | |
| 180-23 | Exhibit 223 - Cognitive, Emotional, and Psychosocial Functioning of Girls TreateExhibit 223 - Cognitive, Emotional, and Psychosocial Functio · Docket 4:22-cv-00325 | 12 | View here · Original(opens another site)PDF, external | |
| 180-24 | Exhibit 224 - Off-label Medication Prescribing Patterns in Pediatrics: An UpdateExhibit 224 - Off-label Medication Prescribing Patterns in P · Docket 4:22-cv-00325 | 8 | View here · Original(opens another site)PDF, external | |
| 180-25 | Exhibit 225 - Functional Ovarian Reserve in Transgender Men Receiving TestosteroExhibit 225 - Functional Ovarian Reserve in Transgender Men · Docket 4:22-cv-00325 | 8 | View here · Original(opens another site)PDF, external | |
| 180-26 | Exhibit 226 - Management of Endocrine Disease: Long term outcome of central precExhibit 226 - Management of Endocrine Disease: Long term out · Docket 4:22-cv-00325 | 10 | View here · Original(opens another site)PDF, external | |
| 180-27 | Exhibit 227 - Presidential Memorandum for the Secretary of Defense and the SecreExhibit 227 - Presidential Memorandum for the Secretary of D · Docket 4:22-cv-00325 | 4 | View here · Original(opens another site)PDF, external | |
| 180-28 | Exhibit 229 - Template Notice of Adverse Benefit DeterminationExhibit 229 - Template Notice of Adverse Benefit Determinati · Docket 4:22-cv-00325 | 4 | View here · Original(opens another site)PDF, external | |
| 180-29 | Exhibit 230 - Template Notice of Plan Appeal ResolutionDocket 4:22-cv-00325 | 2 | View here · Original(opens another site)PDF, external | |
| 180-30 | Exhibit 231 - Sample AHCA Final Order 20-FH0855Docket 4:22-cv-00325 | 8 | View here · Original(opens another site)PDF, external | |
| 180-33 | Exhibit 234A - (Placeholder) Medical records of Brit RothsteinExhibit 234A - (Placeholder) Medical records of Brit Rothste · Docket 4:22-cv-00325 | 1 | View here · Original(opens another site)PDF, external | |
| 181 | Exhibit List (Notice of Filing, Part 7 of 10) by AUGUST DEKKER, JANE DOE, JOHN DOE, SUSAN DOE, K F, JADE LADUE, BRIT ROTHSTEIN.. (Attachments: # 1 Exhibit 237A - (Placeholder) Dekker medical records, # 2 Exhibit 238 - GAPMS Decision Tree Checklist, # 3 Exhibit 239 - GAPMS GnRH for treatment of gender dysphoria, # 4 Exhibit 240 - GAPMS GnRH for treatment of gender dysphoria, # 5 Exhibit 241 - GAPMS Cross Sex Hormone Therapy 5/20/2022, # 6 Exhibit 242 - GAPMS Cross Sex Hormone Therapy Report (edited) - 5/20/2022, # 7 Exhibit 243 - GAPMS Cross Sex Hormone Therapy 11/2/2016, # 8 Exhibit 244 - GAPMS Gender Confirmation Surgery (incomplete) 7/19/2017, # 9 Exhibit 245 - DUR Meeting Transcript 9/26/2015, # 10 Exhibit 246 - DUR Quarterly Report - 2015, # 11 Exhibit 247 - DUR Meeting Minutes 1/16/2016, # 12 Exhibit 248 - DUR Meeting Minutes 9/24/2016, # 13 Exhibit 249 - Pharmacy log 5/31/2016, # 14 Exhibit 250 - AHCA review of research 7/25/2016, # 15 Exhibit 251 - AHCA review of state practice 8/17/2016, # 16 Exhibit 252 - Arlene Elliot research regarding Medicaid coverage of care in other states July 27, 2016, # 17 Exhibit 252A - Arlene Elliot research regarding Medicaid coverage of care in other states July 27, 2016, # 18 Exhibit 252B - Arlene Elliot research regarding Medicaid coverage of care in other states July 27, 2016, # 19 Exhibit 252C - Arlene Elliot research regarding Medicaid coverage of care in other states July 27, 2016, # 20 Exhibit 253 - Aetna clinical criteria for cross-sex hormone therapy 8/18/2016, # 21 Exhibit 254 - Arlene Elliot email re GnRH coverage 8/29/2016, # 22 Exhibit 255 - Rebecca Borgert email regarding Endocrine Society guidelines 8/29/2016, # 23 Exhibit 256 - AHCA GAPMS routing and tracking form for puberty suppression therapy 8/31/2016, # 24 Exhibit 257 - Special services criteria re GnRH coverage 9/20/2016 (updated 11/17/17), # 25 Exhibit 258 - AHCA letter to Childrens Medical Services re drug criteria and coverage 10/6/2016, # 26 Exhibit 259 - AHCA tracking form for GAPMS research re puberty suppression 9/26/2016, # 27 Exhibit 260 - AHCA GAPMS routing and tracking form for cross-sex hormone therapy 11/2/2016, # 28 Exhibit 261 - FL House letter to AHCA re drug treatment for gender dysphoria 11/22/2016, # 29 Exhibit 262 - DUR transcript 3/23/2017, # 30 Exhibit 263 - Draft GAPMS re gender-affirming surgery 7/19/2017, # 31 Exhibit 264 - Email exchange re Medicaid coverage of gender affirming surgery June 2018, # 32 Exhibit 264A - Email exchange re Medicaid coverage of gender affirming surgery June 2018, # 33 Exhibit 265 - AHCA routing form tracking response to MCO question about Medicaid coverage of surgery June 2018, # 34 Exhibit 266 - AHCA document closing the project re responding to MCO question about Medicaid coverage of surgery June 2018, # 35 Exhibit 267 - Email from Theresa Kumar to Jesse Botcher 10/18/2019, # 36 Exhibit 268 - Email from DD Pickle to Krisin Sokoloski 1/5/2022, # 37 Exhibit 269 - AHCA approval of Simply Healthcares provider manual 3/24/2022, # 38 Exhibit 269A - AHCA approval of Simply Healthcares provider manual 3/24/2022, # 39 Exhibit 269B - AHCA approval of Simply Healthcares provider manual 3/24/2022, # 40 Exhibit 269C - AHCA approval of Simply Healthcares provider manual 3/24/2022) (MILLER, WILLIAM) (Entered: 04/27/2023)Exhibit List · Docket 4:22-cv-00325 | 47 | View here · Original(opens another site)PDF, external | |
| 181-2 | Exhibit 238 - GAPMS Decision Tree ChecklistDocket 4:22-cv-00325 | 1 | View here · Original(opens another site)PDF, external | |
| 181-3 | Exhibit 239 - GAPMS GnRH for treatment of gender dysphoriaDocket 4:22-cv-00325 | 8 | View here · Original(opens another site)PDF, external | |
| 181-4 | Exhibit 240 - GAPMS GnRH for treatment of gender dysphoriaDocket 4:22-cv-00325 | 10 | View here · Original(opens another site)PDF, external | |
| 181-5 | Exhibit 241 - GAPMS Cross Sex Hormone Therapy 5/20/2022Docket 4:22-cv-00325 | 13 | View here · Original(opens another site)PDF, external | |
| 181-6 | Exhibit 242 - GAPMS Cross Sex Hormone Therapy Report (edited) - 5/20/2022Exhibit 242 - GAPMS Cross Sex Hormone Therapy Report (edite · Docket 4:22-cv-00325 | 13 | View here · Original(opens another site)PDF, external | |
| 181-7 | Exhibit 243 - GAPMS Cross Sex Hormone Therapy 11/2/2016Docket 4:22-cv-00325 | 16 | View here · Original(opens another site)PDF, external | |
| 181-8 | Exhibit 244 - GAPMS Gender Confirmation Surgery (incomplete) 7/19/2017Exhibit 244 - GAPMS Gender Confirmation Surgery (incomplete · Docket 4:22-cv-00325 | 8 | View here · Original(opens another site)PDF, external |